AZ304

Modify Date: 2024-01-09 12:56:53

AZ304 Structure
AZ304 structure
Common Name AZ304
CAS Number 942507-42-8 Molecular Weight 451.52
Density N/A Boiling Point N/A
Molecular Formula C27H25N5O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of AZ304


AZ304 is an ATP-competitive dual BRAF kinase inhibitor, potently inhibits wild type BRAF, V600E mutant BRAF and wild type CRAF, with IC50s of 79 nM, 38 nM and 68 nM, respectively. AZ304 also has significant effect on other kinases, such as p38 (IC50, 6 nM), CSF1R (IC50, 35 nM). Anti-tumor activity[1].

 Names

Name AZ304

 AZ304 Biological Activity

Description AZ304 is an ATP-competitive dual BRAF kinase inhibitor, potently inhibits wild type BRAF, V600E mutant BRAF and wild type CRAF, with IC50s of 79 nM, 38 nM and 68 nM, respectively. AZ304 also has significant effect on other kinases, such as p38 (IC50, 6 nM), CSF1R (IC50, 35 nM). Anti-tumor activity[1].
Related Catalog
Target

BRafV600E:38 nM (IC50)

BRAFWT:79 nM (IC50)

CRAF:68 nM (IC50)

p38:6 nM (IC50)

CSF1R:35 nM (IC50)

MAP3K7:6400 nM (IC50)

CSK:7050 nM (IC50)

In Vitro AZ304 (1 nM-100 μM) potently reduces ERK phosphorylation (p-ERK), with a mean EC50 of 65 nM in the V600E mutant BRAF containing melanoma cell line A375, and EC50s of 52 nM, 60 nM in the wild type BRAF melanoma cell line SK-MEL-31 with and without EGF[1].AZ304 also potently inhibits p-p38 in both BRAF genetic statuses cell lines[1]. AZ304 (0, 0.1, 1, 10, 100 μM, 48 and 72 hours) dose-dependently inhibits the growth of RKO, HT-29, DiFi, and Caco-2, with GI50s of 4.539 μM, 3.896 μM, 4.987 μM, 1.763 μM (48 hours) and 0.5032 μM, 0.3887 μM, 0.6354 μM, 0.3772 μM (72 hours), respectively[1]. AZ304 (2 μM, 36 and 48 hours) decreases BRAF, p-ERK, p-AKT and p-mTOR levels, increases p-EGFR in both BRAF V600E mutant and BRAF wild type cells. AZ304 down-regulates p-EGFR, inhibits p-ERK, more potently suppresses BRAF, ERK, AKT and mTOR signalling pathways in combination with C225[1]. Cell Proliferation Assay[1] Cell Line: RKO, HT-29, DiFi, Caco-2 cells Concentration: 0, 0.1, 1, 10, 100 μM Incubation Time: 48, 72 hours Result: Dose-dependently inhibited the growth of V600E mutant BRAF cell lines (RKO, HT-29) and wild-type BRAF cell lines (DiFi, Caco-2).
References

[1]. Ma R, et al. AZ304, a novel dual BRAF inhibitor, exerts anti-tumour effects in colorectal cancer independently of BRAF genetic status. Br J Cancer. 2018 May;118(11):1453-1463.

 Chemical & Physical Properties

Molecular Formula C27H25N5O2
Molecular Weight 451.52
Storage condition 2-8℃